🇺🇸 FDA

Drug profile · INN

rilonacept

RILONACEPT FGK REPRESENTATIVE SERVICE GMBH

approved L04AC04
US status
approved
Patents linked
0
News articles
0

Quick answer

rilonacept (RILONACEPT FGK REPRESENTATIVE SERVICE GMBH) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron UK Limited. Route of administration: single-use. Current US regulatory status: approved.

Key facts

INN rilonacept
Brand RILONACEPT FGK REPRESENTATIVE SERVICE GMBH
Route SINGLE-USE
Formulation VIAL
ATC code L04AC04

Frequently asked questions

What is rilonacept?

rilonacept (RILONACEPT FGK REPRESENTATIVE SERVICE GMBH) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron UK Limited. Route of administration: single-use. Current US regulatory status: approved.

What is the brand name for rilonacept?

RILONACEPT FGK REPRESENTATIVE SERVICE GMBH is a marketed brand name for rilonacept. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of rilonacept?

rilonacept has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.